Exercise in Hereditary ATTR (ATTRv) Amyloidosis
Recruiting
N/A
Interventional Study
Amyloidosis, Hereditary, Transthyretin-Related
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 42 (estimated)
- Sponsor
- University of Maia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to explore the effects of a 12-week exercise intervention on the physical and mental health of people living with Hereditary ATTR (ATTRv) Amyloidosis, a rare genetic disease caused by mutations in the transthyretin gene, leading to the deposition of amyloid fibrils in nerves and organs.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ATTRv Amyloidosis patients living in Portugal;
* Disease stage 1 or 2;
* No medical contraindication for exercising;
* Ability to provide informed consent.
Exclusion Criteria:
\- Having undergone a liver transplant in the past 6 months.
Contacts